These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33230163)

  • 1. Application of an open-chamber multi-channel microfluidic device to test chemotherapy drugs.
    Moon HS; Yoo CE; Kim S; Lee JE; Park WY
    Sci Rep; 2020 Nov; 10(1):20343. PubMed ID: 33230163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved microfluidic platform for simultaneous multiple drug screening towards personalized treatment.
    Mitxelena-Iribarren O; Zabalo J; Arana S; Mujika M
    Biosens Bioelectron; 2019 Jan; 123():237-243. PubMed ID: 30224287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A microfluidic gradient device for drug screening with human iPSC-derived motoneurons.
    Mo SJ; Lee JH; Kye HG; Lee JM; Kim EJ; Geum D; Sun W; Chung BG
    Analyst; 2020 Apr; 145(8):3081-3089. PubMed ID: 32150196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Integrated Microfluidics Approach for Personalized Cancer Drug Sensitivity and Resistance Assay.
    Desyatnik I; Krasner M; Frolov L; Ronen M; Guy O; Wasserman D; Tzur A; Avrahami D; Barbiro-Michaely E; Gerber D
    Adv Biosyst; 2019 Nov; 3(11):e1900001. PubMed ID: 32648689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on microfluidics manipulation of the extracellular chemical microenvironment and its emerging application to cell analysis.
    Chen P; Li S; Guo Y; Zeng X; Liu BF
    Anal Chim Acta; 2020 Aug; 1125():94-113. PubMed ID: 32674786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications.
    Mark D; Haeberle S; Roth G; von Stetten F; Zengerle R
    Chem Soc Rev; 2010 Mar; 39(3):1153-82. PubMed ID: 20179830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug screening on digital microfluidics for cancer precision medicine.
    Zhai J; Liu Y; Ji W; Huang X; Wang P; Li Y; Li H; Wong AH; Zhou X; Chen P; Wang L; Yang N; Chen C; Chen H; Mak PI; Deng CX; Martins R; Yang M; Ho TY; Yi S; Yao H; Jia Y
    Nat Commun; 2024 May; 15(1):4363. PubMed ID: 38778087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients.
    Al-Samadi A; Poor B; Tuomainen K; Liu V; Hyytiäinen A; Suleymanova I; Mesimaki K; Wilkman T; Mäkitie A; Saavalainen P; Salo T
    Exp Cell Res; 2019 Oct; 383(2):111508. PubMed ID: 31356815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances on open fluidic systems for biomedical applications: A review.
    Oliveira NM; Vilabril S; Oliveira MB; Reis RL; Mano JF
    Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():851-863. PubMed ID: 30678977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-gradient constructions in a flow-rate insensitive microfluidic system for drug screening towards personalized treatment.
    Shen S; Zhang X; Zhang F; Wang D; Long D; Niu Y
    Talanta; 2020 Feb; 208():120477. PubMed ID: 31816765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scalable Multiplexed Drug-Combination Screening Platforms Using 3D Microtumor Model for Precision Medicine.
    Zhang Z; Chen YC; Urs S; Chen L; Simeone DM; Yoon E
    Small; 2018 Oct; 14(42):e1703617. PubMed ID: 30239130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Static Molecular Gradients in a High-Throughput Drug Screening Microfluidic Assay.
    Szafran RG; Wiatrak B
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Models for Personalized Medicine: from Conventional Models to Microfluidic Primary Intestine-on-a-chip.
    Li XG; Chen MX; Zhao SQ; Wang XQ
    Stem Cell Rev Rep; 2022 Aug; 18(6):2137-2151. PubMed ID: 34181185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manually operatable on-chip bistable pneumatic microstructures for microfluidic manipulations.
    Chen A; Pan T
    Lab Chip; 2014 Sep; 14(17):3401-8. PubMed ID: 25007840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug screening of cancer cell lines and human primary tumors using droplet microfluidics.
    Wong AH; Li H; Jia Y; Mak PI; Martins RPDS; Liu Y; Vong CM; Wong HC; Wong PK; Wang H; Sun H; Deng CX
    Sci Rep; 2017 Aug; 7(1):9109. PubMed ID: 28831060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Versatile membrane-based microfluidic platform for in vitro drug diffusion testing mimicking in vivo environments.
    Mitxelena-Iribarren O; Olaizola C; Arana S; Mujika M
    Nanomedicine; 2022 Jan; 39():102462. PubMed ID: 34592426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilayer architecture microfluidic network array for combinatorial drug testing on 3D-cultured cells.
    Chang HC; Lin CH; Juang D; Wu HW; Lee CY; Chen C; Hsu CH
    Biofabrication; 2019 Jun; 11(3):035024. PubMed ID: 31051482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconfigurable virtual electrowetting channels.
    Banerjee A; Kreit E; Liu Y; Heikenfeld J; Papautsky I
    Lab Chip; 2012 Feb; 12(4):758-64. PubMed ID: 22159496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microfluidic cell culture array chip for drug screening assays].
    Zheng Y; Wu J; Shao J; Jin Q; Zhao J
    Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):779-85. PubMed ID: 19670650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening.
    Lee JB; Sung JH
    Biotechnol J; 2013 Nov; 8(11):1258-66. PubMed ID: 24038956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.